<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">25408753</PMID>
      <DateCompleted>
        <Year>2015</Year>
        <Month>07</Month>
        <Day>10</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>31</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1844-3117</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>7</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2014</Year>
              <Month>Sep</Month>
              <Day>15</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of medicine and life</Title>
          <ISOAbbreviation>J Med Life</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Endometriosis still a challenge.</ArticleTitle>
        <Pagination>
          <StartPage>349</StartPage>
          <EndPage>357</EndPage>
          <MedlinePgn>349-57</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText>Endometriosis is a debilitating disease with features of chronic inflammation. Endometriosis appears to be one of the most common benign gynecological proliferations in premenopausal women since it is estimated that 10-15% of reproductive aged women suffer from pelvic endometriosis. The biology of endometriosis is unclear. Despite its prevalence, this disease remains poorly understood and current studies prove that there is no relationship between the extent of the disease and its symptomatology. There is no blood test available for the diagnosis of endometriosis. Up to this point, there is no single very successful option for the treatment of endometriosis. Due to the relatively poor efficacy of hormonal therapy for endometriosis, several other experimental therapies are currently undergoing clinical trial.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Mehedintu</LastName>
            <ForeName>C</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>"Nicolae Malaxa" Clinical Hospital.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Plotogea</LastName>
            <ForeName>M N</ForeName>
            <Initials>MN</Initials>
            <AffiliationInfo>
              <Affiliation>"Nicolae Malaxa" Clinical Hospital.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ionescu</LastName>
            <ForeName>S</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>"Nicolae Malaxa" Clinical Hospital.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Antonovici</LastName>
            <ForeName>M</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>"Nicolae Malaxa" Clinical Hospital.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2014</Year>
          <Month>09</Month>
          <Day>25</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>J Med Life</MedlineTA>
        <NlmUniqueID>101477617</NlmUniqueID>
        <ISSNLinking>1844-122X</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D003278">Contraceptives, Oral, Hormonal</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D004147">Dioxins</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003278" MajorTopicYN="N">Contraceptives, Oral, Hormonal</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004147" MajorTopicYN="N">Dioxins</DescriptorName>
          <QualifierName UI="Q000633" MajorTopicYN="N">toxicity</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004715" MajorTopicYN="N">Endometriosis</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008598" MajorTopicYN="N">Menstruation</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008954" MajorTopicYN="Y">Models, Biological</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">dysmenorrhea</Keyword>
        <Keyword MajorTopicYN="N">endometriosis</Keyword>
        <Keyword MajorTopicYN="N">endometriosis therapy</Keyword>
        <Keyword MajorTopicYN="N">fertility</Keyword>
        <Keyword MajorTopicYN="N">pain</Keyword>
      </KeywordList>
      <CoiStatement>Disclosures, Funding and Conflicts of Interest: None specified</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2014</Year>
          <Month>3</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2014</Year>
          <Month>6</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2014</Year>
          <Month>11</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2014</Year>
          <Month>11</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2015</Year>
          <Month>7</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">25408753</ArticleId>
        <ArticleId IdType="pmc">PMC4233437</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Olive  DL. Endometriosis in Clinical Practice. London and New York: Taylor and Francis. 2005</Citation>
        </Reference>
        <Reference>
          <Citation>Flores  I, Rivera  E. Molecular profiling of experimental endometriosis identified gene expression patterns in common with human disease. Fertility and Sterility. 2007;87:1180–1199.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1927082</ArticleId>
            <ArticleId IdType="pubmed">17478174</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Van Gorp  T, Amant  F. Endometriosis and the development of malignant tumours of the pelvis. A review of literature. Best Practice and Research. . Clinical Obstetrics and Gynaecology. 2004;18:349–371.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15157647</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crisan  N, Nanu  D, compilers.  In: Ginecologie. Bucuresti: Ed. Stiinta si tehnica; </Citation>
        </Reference>
        <Reference>
          <Citation>Fauconnier  A, Chapron  C. Relation between pain symptoms and the anatomic location of deep infiltrating endometriosis. Fertil Steril. 2002;78:719–726.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12372446</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sutton  C, Jones  K, compilers.  In: Modern Management of Endometriosis. Abingdon, Oxon: Taylor and Francis; 2005. </Citation>
        </Reference>
        <Reference>
          <Citation>Fukunaga  M. Uterus‐like mass in the uterine cervix: superficial cervical endometriosis with florid smoothmuscle metaplasia? Virchows Arch. 2001;438:302–305.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11315628</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mounsey  A, Wilgus  A. Diagnosis and management of endometriosis. Am Fam Phys. 2006;74:594–600.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16939179</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Halme  J. Retrograde menstruation in healthy women and in patients with endometriosis. Obstet Gynecol. 1984;64:151–154.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6234483</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barcena de Arellano  ML, Gericke J. Immunohistochemical characterization of endometriosis‐associated smooth muscle cells in humanperitoneal endometriotic lesions. Hum Reprod. 26:2721–2730.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21831994</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sampson  J. Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity. Obstet Gynecol. 1927;14:422–469.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1931779</ArticleId>
            <ArticleId IdType="pubmed">19969738</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Braundmeier  AG, Fazleabas  AT. The non-human primate model of endometriosis: research and implications for fecundity. Mol Hum Reprod. 2009;15:577–586.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2744471</ArticleId>
            <ArticleId IdType="pubmed">19633013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Giudice  LC, Kao  LC. Endometriosis. Lancet. 2004;364:1789–1799.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15541453</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gruenwald  P. Origin of endometriosis form the mesenchyme of the celomic walls. Am J Obstet Gynecol. 1942;44:470–474.</Citation>
        </Reference>
        <Reference>
          <Citation>Jubanyik  KJ, Comite  F. Extrapelvic endometriosis. Obstet Gynecol Clin North Am. 1997;24:411–440.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9163774</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu  MY, Ho  HN. The role of cytokines in endometriosis. Am J Reprod Immunol. 2003;49:285–296.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12854733</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Szyllo  K. The involvement of T lymphocytes in the pathogenesis of endometriotic tissues overgrowth in women with endometriosis. Mediators Inflamm. 2003;12:131–138.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1781609</ArticleId>
            <ArticleId IdType="pubmed">12857596</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hadfield  RM, Mardon  HJ. Endometriosis in monozygotic twins. Fertil Steril. 1997;68:941–942.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9389831</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fraga  MF, Ballestar  E. Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci USA. 2005;102:10604–10609.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1174919</ArticleId>
            <ArticleId IdType="pubmed">16009939</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bischoff  F, Simpson  JL. Genetics of endometriosis: heritability and candidate genes. Best Pract Res Clin Obstet Gynaecol. 2004;18:219–232.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15157639</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Campbell  IG, Thomas  EJ. Endometriosis: candidate genes. Hum Reprod Update. 2001;7:15–20.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11212068</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vigano  P. Genetics of endometriosis: current status and prospects. Front Biosci. 2007;12:3247–3255.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17485295</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tempfer  CB. Functional genetic polymorphisms and female reproductive disorders: part II--endometriosis. Hum Reprod Update. 2009;15:97–118.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2639061</ArticleId>
            <ArticleId IdType="pubmed">18805939</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Treloar  SA. Genomewide linkage study in 1,176 affected sister pair families identifies a significant susceptibility locus for endometriosis on chromosome 10q26. Am J Hum Genet. 2005;77:365–376.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1226203</ArticleId>
            <ArticleId IdType="pubmed">16080113</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Painter  JN. Genome-wide association study identifies a locus at 7p15.2 associated with endometriosis. Nat Genet. 43:51–54.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3019124</ArticleId>
            <ArticleId IdType="pubmed">21151130</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zondervan  KT, Weeks  DE. Familial aggregation of endometriosis in a large pedigree of rhesus macaques. Hum Reprod. 2004;19:448–455.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14747196</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lopez  J. The context and potential of epigenetics in oncology. Br J Cancer. 2009;100:571–577.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2653733</ArticleId>
            <ArticleId IdType="pubmed">19223907</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bartova  E. Chromatin structure and epigenetics of tumour cells: a review. Cardiovasc Hematol Disord Drug Targets. 2009;9:51–61.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19275577</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guo  SW. Epigenetics of endometriosis. Mol Hum Reprod. 2009;15:587–607.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19651637</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fjerbaek  A, Knudsen  UB. Endometriosis, dysmenorrhea and diet--what is the evidence? Eur J Obstet Gynecol Reprod Biol. 2007;132:140–147.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17210218</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Parazzini  F. Selected food intake and risk of endometriosis. Hum Reprod. 2004;19:1755–1759.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15254009</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang  JZ, Agarwal  SK. Subchronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin modulates the pathophysiology of endometriosis in the cynomolgus monkey. Toxicol Sci. 2000;56:374–381.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10910996</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guo  SW. The link between exposure to dioxin and endometriosis: a critical reappraisal of primate data. Gynecol Obstet Invest. 2004;57:157–173.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14739528</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>34. W.H.O Level of PCB's, PCDD's and PCDF's in breast milk: result of WHO coordinated inter-laboratory quality control studies and analytical field studies. WHO Environmental Health Series. 1989</Citation>
        </Reference>
        <Reference>
          <Citation>Eskenazi  B. Serum dioxin concentrations and endometriosis: a cohort study in Seveso, Italy. Environ Health Perspect. 2002;110:629–634.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1240907</ArticleId>
            <ArticleId IdType="pubmed">12117638</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Porpora  MG. Increased levels of polychlorobiphenyls in Italian women with endometriosis. Chemosphere. 2006;63:1361–1367.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16289286</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>37. ESHRE Special Interest Group for Endometriosis and Endometrium Guideline Development Group ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod. 2005;120:2698–2704.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15980014</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fauconnier  A, Chapron  C. Relation between pain symptoms and the anatomic location of deep infiltrating endometriosis. Fertil Steril. 2002;78:719–726.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12372446</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kazakov  DV, Ondic  O. Morphological variations of scar‐related and spontaneous endometriosis of the skin and superficial soft tissue: a study of 71 cases with emphasis on atypical features and types of mullerian differentiations. J Am Acad Dermatol. 2007;57:134–146.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17572279</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>D’Hooghe  TM, Mihalyi  AM. Why we need a noninvasive diagnostic test for minimal to mild endometriosis with a high sensitivity. Gynecologic and Obstetric Investigation. 2006;62:136–138.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16679771</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Agic  A. Combination of CCR1 mRNA, MCP1, and CA125 measurements in peripheral blood as a diagnostic test for endometriosis. Reprod Sci. 2008;15:906–911.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19050323</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kitawaki  J. Endometriosis: the pathophysiology as an estrogen-dependent disease. J Steroid Biochem Mol Biol. 2002;83:149–155.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12650711</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vercellini  P. Endometriosis: current therapies and new pharmacological developments. Drugs. 2009;69:649–675.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19405548</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meresman  GF, Auge  L. Oral contraceptives suppress cell proliferation and enhance apoptosis of eutopic endometrial tissue from patients with endometriosis. Fertil Steril. 2002;77:1141–1147.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12057719</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vercellini  P, Trespidi  L. A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis. Fertil Steril. 1993;60:75–79.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8513962</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Parazzini  F, Di Cintio  E. Estroprogestin vs. gonadotrophin agonists plus estroprogestin in the treatment of endometriosis-related pelvic pain: a randomized trial. Gruppo Italiano per lo Studio dell’Endometriosi. Eur J Obstet Gynecol Reprod Biol. 2000;88:11–14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10659911</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Coffee  AL, Sulak  PJ. Long-term assessment of symptomatology and satisfaction of an extended oral contraceptive regimen. Contraception. 2007;75:444–449.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17519150</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vercellini  P. Progestogens for endometriosis: forward to the past. Hum Reprod Update. 2003;9:387–396.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12926531</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schenken  RS. Endometriosis: Contemporary Concepts in Clinical Management. 1989</Citation>
        </Reference>
        <Reference>
          <Citation>Harada  T, Taniguchi  F. Dienogest: a new therapeutic agent for the treatment of endometriosis. Womens Health. 2010;6:27–35.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20001868</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Petta  CA, Ferriani  RA. Randomized clinical trial of a levonorgestrel releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis. Hum Reprod. 2005;20:1993–1998.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15790607</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yisa  SB, Okenwa  AA. Treatment of pelvic endometriosis with etonogestrel subdermal implant (Implanon) J Fam Plann Reprod Health Care. 2005;31:67–70.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15720856</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Buttram  VC Jr, Belue  JB. Interim report a study of danazol for the treatment of endometriosis. Fertil Steril. 1982;37:478–483.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7067844</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alvarado  RG, Liu  JY. Danazol and limb-threatening arterial thrombosis: two case reports. J Vasc Surg. 2001;34:1123–1126.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11743571</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sharpe-Timms  KL. Gonadotropin-releasing hormone agonist (GnRH-a) therapy alters activity of plasminogen activators, matrix metalloproteinases, and their inhibitors in rat models for adhesion formation and endometriosis: potential GnRH-a-regulated mechanisms reducing adhesion formation. Fertil Steril. 1998;69:916–923.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9591503</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kitawaki  J, Ishihara  H. Maintenance therapy involving a tapering dose of danazol or mid/low doses of oral contraceptive after gonadotropin-releasing hormone agonist treatment for endometriosis-associated pelvic pain. Fertil Steril. 2008;89:1831–1835.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17761178</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kupker  W, Felberbaum  RE. Use of GnRH antagonists in the treatment of endometriosis. Reprod Biomed Online. 2002;5:12–16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12470539</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anderes  KL, Luthin  DR. Biological characterization of a novel, orally active small molecule gonadotropin-releasing hormone (GnRH) antagonist using castrated and intact rats. J Pharmacol Exp Ther. 2003;305:688–695.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12606616</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lall Seal  S. Aromatase inhibitors in recurrent ovarian endometriomas: report of five cases with literature review. Fertil Steril. 95:e15–e18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20579642</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bulun  SE, Simpson  ER. Aromatase expression in women's cancers. Adv Exp Med Biol. 2008;630:112–132.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18637488</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Suzuki  T. In situ production of sex steroids in human breast carcinoma. Med Mol Morphol. 2007;40:121–127.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17874044</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stratton  P, Sinaii  N. Return of chronic pelvic pain from endometriosis after raloxifene treatment: a randomized controlled trial. Obstet Gynecol. 2008;111:88–96.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2755201</ArticleId>
            <ArticleId IdType="pubmed">18165396</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pasqualetti  G. Vascular endothelial growth factor pharmacogenetics: a new perspective for anti-angiogenic therapy. Pharmacogenomics. 2007;8:49–66.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17187509</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hassan  MH. Gene therapy of benign gynecological diseases. Adv Drug Deliv Rev. 2009</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4477532</ArticleId>
            <ArticleId IdType="pubmed">19446586</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Othman  EE. Toward gene therapy of endometriosis: adenovirus-mediated delivery of dominant negative estrogen receptor genes inhibits cell proliferation, reduces cytokine production, and induces apoptosis of endometriotic cells. Fertil Steril. 2007;88:462–471.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17343855</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boing  C, Kimmig  R. Surgical management of endometriosis––an overview. Gynakol Geburtshilfliche Rundsch. 2007;47:124–131.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17641475</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Koninckx  PR. Suggestive evidence that pelvic endometriosis is a progressive disease, whereas deeply infiltrating endometriosis is associated with pelvic pain. Fertil Steril. 1991;55:759–765.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2010001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yoshida  S, Harada  T. Laparoscopic surgery for the management of ovarian endometrioma. Gynecol Obstet Invest. 2002;54:24–27.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12441657</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shakiba  K. Surgical treatment of endometriosis: a 7-year follow-up on the requirement for further surgery. Obstet Gynecol. 2008;111:1285–1292.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18515510</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
